USP20 and hypopharyngeal carcinoma: Together, these findings suggest that USP20 and CTSL are closely linked to metastatic progression and poor clinical outcomes in hypopharyngeal carcinoma, highlighting their potential as prognostic biomarkers and therapeutic targets.